AstraZeneca breast cancer drug that slows disease progression approved for earlier use

A breast cancer drug previously available as a treatment for certain later-stage tumors has been approved for earlier use in the United States after a phase 3 trial showed it reduced the risk of disease progression or death by 72% compared to another common treatment for patients with HER2 positive metastatic breast cancer. “This is an important day for the breast cancer community,” said Catherine Ormerod, executive vice president, Strategy and Mission, Living Beyond Breast Cancer. Enhertu…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news